Jincheng Pharmaceutical: Announcement on the cancellation of repurchased shares, reduction of registered capital and revision of the Articles of Association
Securities code: 300233 Securities abbreviation: Jincheng Pharmaceutical Announcement number: 2026-054
Shandong Jincheng Pharmaceutical Group Co., Ltd.
Announcement on the cancellation of repurchased shares, reduction of registered capital and revision of the Articles of Association
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.
Shandong Jincheng Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") held the fourth meeting of the seventh board of directors on August 19, 2026, and reviewed and approved the "Proposal on Changing the Use of Repurchased Shares and Cancellation", decided to cancel 4,543,000 shares in the company's special repurchase securities account, and submitted the proposal to the company's first extraordinary shareholders' meeting in 2026 for review.
1. Repurchase of shares
On February 2, 2024, the company held the seventh meeting of the sixth board of directors and reviewed and approved the "Proposal on Repurchasing Part of Public Shares through Centralized Bidding." The total amount of repurchase funds shall not be less than RMB 50 million (inclusive) and not exceed RMB 70 million (inclusive), the price of repurchased shares shall not exceed RMB 22.00 per share, and the period for repurchasing shares shall be within 3 months from the date when the board of directors considers and approves the share repurchase plan. On February 8, 2024, the company disclosed the "Announcement on the Implementation Results of Share Repurchase and Changes in Shares", and the company's repurchase plan was completed.
As of February 8, 2024, the company has repurchased a total of 4,543,000 shares of the company through centralized bidding transactions through the special repurchase account, accounting for 1.18% of the company's total share capital. The highest transaction price was 14.56 yuan/share, the lowest transaction price was 10.89 yuan/share, and the total transaction amount was 55,004,340.17 yuan (excluding transaction fees).
2. Reasons for cancellation of repurchased shares
According to the relevant provisions of the "Share Repurchase Rules for Listed Companies", shares repurchased by a company "necessary to safeguard the company's value and shareholders' rights and interests" must be transferred within three years in accordance with the purpose disclosed in accordance with the law. If the transfer is not carried out in accordance with the disclosed purpose, it shall be canceled before the expiration of the three-year period. Therefore, after deliberation and approval at the fourth meeting of the company's seventh board of directors, it was decided to cancel 4,543,000 shares in the company's special repurchase securities account and reduce the registered capital.
3. Changes in shares and amendments to the articles of association after cancellation and repurchase
After the shares are canceled and the registered capital is reduced, the company's total share capital will be reduced from 383,874,587 shares to 379,331,587 shares, and the registered capital will be reduced from 383,874,587 yuan to 379,331,587 yuan. Some articles of the Articles of Association are revised as follows:
Before revision After revision
Article 6 The registered capital of the company is RMB. Article 6 The registered capital of the company is RMB.
383,874,587 yuan. 379,331,587 yuan.
If a company's total registered capital changes due to an increase or decrease in its registered capital, after the shareholders' meeting passes a resolution agreeing to increase or decrease the registered capital, the board of directors may be authorized to specifically handle matters that amend the "Articles of Association" and registration procedures for changes in registered capital. Registration procedures for changes in capital.
Article 20 The total number of shares of the company is 383,874,587. Article 20 The total number of shares of the company is 379,331,587 shares. The company’s capital structure is: 383,874,587 ordinary shares. 379,331,587 shares.
Except for the above provisions, other provisions of the Articles of Association remain unchanged. The corresponding provisions of this revision of the "Articles of Association", after being reviewed and approved by a special resolution of the company's shareholders' meeting, will authorize the company's management to handle relevant procedures such as industrial and commercial changes.
4. Review status
On August 19, 2026, the fourth meeting of the company's seventh board of directors reviewed and approved the "Proposal on Changing the Use and Cancellation of Repurchased Shares" and agreed to submit the proposal to the company's first extraordinary shareholders' meeting in 2026 for review.
5. Documents for reference
- Resolution of the fourth meeting of the seventh board of directors.
Announcement is hereby made.
Board of Directors of Shandong Jincheng Pharmaceutical Group Co., Ltd.
August 21, 2026